According to a previous clinical study, upregulation of AKR1C3 is an indicator of poor prognosis in HPV16-associated and HPV-negative oropharyngeal squamous cell carcinoma (OPSCC) (60). This evidence concerns the gene AKR1C3 and oropharynx squamous cell carcinoma.